Steven Cohen’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
+447,197
New +$2.02M ﹤0.01% 2576
2026
Q2
– Sell
-1,680,449
Closed -$9.6M – 4352
2026
Q1
$9.6M Sell
1,680,449
-214,273
-11% -$1.52M 0.01% 1283
2025
Q4
$18.8M Sell
1,894,722
-47,127
-2% -$430K 0.02% 931
2025
Q3
$12.9M Buy
1,941,849
+1,293,969
+200% +$6.26M 0.02% 705
2025
Q2
$2.6M Sell
647,880
-450,263
-41% -$1.48M 0.01% 1190
2025
Q1
$3.81M Buy
1,098,143
+347,908
+46% +$1.54M 0.01% 1026
2024
Q4
$4.94M Buy
750,235
+379,828
+103% +$2.99M 0.01% 949
2024
Q3
$3.35M Buy
+370,407
New +$4.42M 0.01% 1001

Other funds holding LXEO

Steven Cohen's LXEO Position: Q3 2026 in Review

Steven Cohen opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 447,197 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #2576 among its holdings. This is a return to the name: Steven Cohen previously reported a position in LXEO as recently as Q1 2026.

Steven Cohen first reported a position in LXEO in Q3 2024 and has held it in 8 quarters since. The position peaked at $18.8M in Q4 2025. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • Steven Cohen held 447,197 shares of Lexeo Therapeutics worth $1.51M as of Q3 2026.
  • Lexeo Therapeutics was a new Steven Cohen position in Q3 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2576 holding.
  • Steven Cohen first reported a position in Lexeo Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Steven Cohen's Lexeo Therapeutics position peaked at $18.8M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.